NCI's genomic characterization center - IDIQ contract

Ended Awarded Last action

Contract number
75N91019F00129
Awardee
Awarding agency
Obligated
$2,675

Award facts

Opportunity
Contract value 100% obligated
$2,675.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541990 All Other Professional, Scientific, and Technical Services
PSC
B529 Special Studies/Analysis- Scientific Data
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
South Plainfield, NJ 07080, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute issued a $2,675 delivery order to Genewiz, LLC on August 31, 2019, under the NCI Genomic Characterization Centers IDIQ for genomic characterization services supporting the Center for Cancer Genomics.

The NCI Genomic Characterization Centers IDIQ provides cancer genomics capabilities to the National Cancer Institute. Place of performance is South Plainfield, NJ. The order was firm fixed price with an ultimate completion date of August 30, 2020.

Quick answers

Who was awarded contract 75N91019F00129?

75N91019F00129 was awarded to Genewiz, LLC by National Cancer Institute (National Institutes of Health) on August 31, 2019.

How much is contract 75N91019F00129 worth?

The government has obligated $2,675 on 75N91019F00129.

Is contract 75N91019F00129 an order under another contract?

Yes. 75N91019F00129 is a delivery order under 75N91019D00030, an indefinite delivery contract, on NCI Genomic Characterization Centers.

Was contract 75N91019F00129 competed?

The extent of competition for 75N91019F00129 was full and open competition. The government received 5 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award